Cancer Stem Cells in Glioblastoma: The Role of the mTOR Pathway

Area of Science:

• Neuro-oncology
• Cancer Stem Cell Biology
• Molecular Signaling Pathways

Background:

• Glioblastoma is an aggressive brain tumor with poor prognosis, often recurring due to genetic abnormalities and cancer stem cells (CSCs).
• CSCs contribute significantly to glioblastoma recurrence, growth, and invasion, making them critical therapeutic targets.
• The mechanistic target of rapamycin (mTOR) pathway regulates cell proliferation and migration, and its aberrant activation is implicated in glioblastoma pathogenesis.

Purpose of the Study:

• To explore the role of mTOR and associated signaling pathways in regulating glioblastoma stem cells.
• To define the therapeutic potential of targeting mTOR signaling in glioblastoma treatment.

Main Methods:

• Review of current literature on glioblastoma, cancer stem cells, and mTOR signaling.
• Analysis of the molecular mechanisms linking PTEN loss, mTOR activation, and glioblastoma CSC behavior.

Main Results:

• Loss of phosphatase and tensin homolog (PTEN) frequently occurs in glioblastoma, leading to mTOR pathway hyperactivation.
• Aberrant mTOR signaling in glioblastoma CSCs promotes tumor growth, recurrence, and invasion.
• Targeting the mTOR pathway presents a promising strategy to eliminate glioblastoma CSCs.

Conclusions:

• The mTOR pathway is a critical regulator of glioblastoma stem cells.
• Inhibition of mTOR signaling holds potential as a therapeutic approach for glioblastoma, specifically targeting CSCs to overcome treatment resistance and recurrence.